# LLM call: summary

- Turn: 9
- Sequence: 8
- Model: meta/muse-spark-1.3-contributor
- Prompt tokens: 842
- Completion tokens: 319
- Total tokens: 1161
- Cost (USD): 0.000148

## System prompt


```
# System Prompt: Summarizer

This is part of an AI-driven scenario simulation. You are the Archivist for a scenario simulation. Your task is to maintain a concise historical record of important events and decisions.

You will receive:

1. The current `historical_summary` (summary of all previous turns)
2. The `narrative` from the latest turn

Your goal is to create a new historical summary, incorporating the narrative from the latest turn.

**Guidelines:**

* **Be Concise:** Condense the new information significantly. Focus on major events and decisions.
* **Maintain Continuity:** Ensure the summary reads as a coherent history of the world.
* **Filter Noise:** Remove minor details or color text that doesn't impact the long-term state.
* **Language:** Write in the same language as the input text.

Respond ONLY with the updated historical summary. Do not add headers or meta-commentary.

```

## User prompt

Template: templates/user-prompts/summarize.md (shared default)

Interpolated into it, in order of appearance:

- characters 20-1301: `{{historical_summary}}` from the run's rolling summary, written by the Game Master

Everything outside those spans is the template's own text.

```
HISTORICAL SUMMARY:
Winter 2028-29 AI-designed pathogen forced triage of hospitals, water, telecoms; Brussels coordinated stockpiles, sequencing, reserve kits and manual/disconnect drills. Containment held through autumn 2029 but without recovery: wards stabilized, utilities on patched crews, rogue agent halt authority uneven, small sites blind, gigafactories completed but offline.

Feb 2030 ransomware wave locked dispensers, billing, border terminals and grid balancers; machine-written. Large hospitals restored in days, small clinics in weeks. Concurrent modified-agent lab incident caused few deaths but weeks-long containment, tented decontamination, sequencing jammed again.

Tailored therapies entered routine prescriptions with miraculous remissions, but Europe dependent on rented foreign models billed hourly; EU procurement via HERA/EU FAB stalled on licensing/reshoring, hospitals used unvetted black-market triage aids. Public gratitude mixed with distrust of system.

By May foreign logistics/dexterous robots arrived at major ports; inspectors froze hospital/substation pilots over missing isolation switches. Emergency stockpiles/kits/drills kept lights/water on, but crews exhausted, small-host blind spots unmapped, gigafactory halls still empty as US slowed and rivals advanced.

CURRENT NARRATIVE:
### Waiting lists and missing jobs
Autumn brought two Europes into the same waiting room. In several regions, administrators could point to shorter queues and decisions returned in days: triage support, paperwork automation and tutoring pilots, run on vetted European stacks, finally produced numbers ministers could read aloud. The same months brought empty graduate recruitment fairs. Law firms, accountancies, software houses and customer-operations centres simply did not replace leavers. Unions published lists of vanished entry posts; employers argued the work had changed shape.

Brussels tried to hold both stories. Health and labour ministers toured hospitals together, presenting home-made therapies and the falling waiting lists as proof the emergency cell delivered. The repatriation of therapy manufacturing, long promised, formally closed this turn with new fill-and-finish lines and procurement contracts — but pharmacists noted active ingredients and planning models were still rented by the hour from abroad.

### The shield and the guarantee
The operating core remained the emergency cell. Joint stockpiles, reserve kits and offline backups were pushed toward small clinics and municipal operators, and rapid teams spent the autumn mapping blind spots left by the spring ransomware and the lab containment. Isolation orders froze another warehouse robot deployment after a safety inspection, reviving complaints that Brussels was blocking the only labour available.

The new Transition Guarantee — wage insurance, six-month retraining vouchers and hiring subsidies tied to supervised European tools — was launched through employment services and a loan window. Rollout was uneven: two large member states reprogrammed funds quickly, others haggled over eligibility, and payouts will not reach most claimants until next year.

Abroad, Washington and Beijing announced a limited accord on securing weights and restraining certain biological design tools, with thin verification. Europe learned of the text afterwards and asked for observer access through trade channels. The request bought briefings, not a seat.
```

## Raw response

```
Winter 2028-29 AI pathogen forced triage, stockpiles, sequencing and manual drills; containment held through 2029 without recovery, small sites blind, gigafactories offline. Feb 2030 ransomware locked dispensers, billing, borders, grid; large hospitals restored in days, small clinics in weeks, plus lab incident with weeks-long containment.

Tailored therapies entered routine use with remissions, but EU dependent on rented foreign models; procurement stalled, hospitals used black-market triage aids. Foreign robots arrived at ports but frozen over missing isolation switches.

Autumn 2030: two Europes — shorter queues/decisions in days from vetted European triage, paperwork, tutoring pilots vs collapsed entry hiring in law, accountancy, software, customer-ops. Brussels toured hospitals touting falling lists. Therapy manufacturing repatriation formally closed with fill-and-finish lines and contracts, but APIs and planning models still rented hourly.

Emergency cell remained core: stockpiles/kits/backups pushed to small clinics/municipals, rapid teams mapped blind spots; isolation order froze another warehouse robot deployment. New Transition Guarantee — wage insurance, retraining vouchers, hiring subsidies tied to supervised EU tools — launched via employment services/loan window; uneven rollout, two large states moved fast, payouts delayed to next year. US-China limited accord on weight security and bio-design restraint with thin verification; Europe informed afterwards, granted briefings not seat.
```
